These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10937732)

  • 1. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.
    Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.
    Ivachtchenko AV; Mitkin OD; Tkachenko SE; Okun IM; Kysil VM
    Eur J Med Chem; 2010 Feb; 45(2):782-9. PubMed ID: 19939513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands.
    Isaac MB; Xin T; O'Brien A; St-Martin D; Naismith A; MacLean N; Wilson J; Demchyshyn L; Tehim A; Slassi A
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2451-4. PubMed ID: 12161155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT6 receptor antagonists.
    Fabritius CH; Pesonen U; Messinger J; Horvath R; Salo H; Gałęzowski M; Galek M; Stefańska K; Szeremeta-Spisak J; Olszak-Płachta M; Buda A; Adamczyk J; Król M; Prusis P; Sieprawska-Lupa M; Mikulski M; Kuokkanen K; Chapman H; Obuchowicz R; Korjamo T; Jalava N; Nowak M
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2610-5. PubMed ID: 27117428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
    Vera G; Lagos CF; Almendras S; Hebel D; Flores F; Valle-Corvalán G; Pessoa-Mahana CD; Mella-Raipán J; Montecinos R; Recabarren-Gajardo G
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27537868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
    J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor.
    Kikuchi C; Nagaso H; Hiranuma T; Koyama M
    J Med Chem; 1999 Feb; 42(4):533-5. PubMed ID: 10052959
    [No Abstract]   [Full Text] [Related]  

  • 11. Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
    Kambhampati R; Konda J; Reballi V; Shinde AK; Dubey PK; Nirogi RV
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):302-12. PubMed ID: 18569332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists.
    Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor.
    Ivachtchenko AV; Dmitriev DE; Golovina ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Okun IM; Tkachenko SE; Vorobiev AA
    J Med Chem; 2010 Jul; 53(14):5186-96. PubMed ID: 20560595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266.
    Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G
    Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity.
    Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G
    J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
    Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR
    Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.
    Kikuchi C; Suzuki H; Hiranuma T; Koyama M
    Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.